Navidea Biopharmaceuticals News

0,203 $ -2,40% -0,005 $
In Euro: 0,1791 € | 14.11.18 21:59:57 Uhr AMEX | Mehr Kurse »
WKN: A1JSBX
ISIN: US63937X1037
US-Symbol: NAVB
Typ: Aktie

Navidea Biopharmaceuticals News

  
07.11.18 Navidea Biopharmaceuticals Reports Third Quarter 2018 Financial Results Businesswire
01.11.18 Navidea Biopharmaceuticals Schedules Third Quarter 2018 Earnings Conference Call and Business Update Businesswire
31.10.18 Navidea Biopharmaceuticals Wins Dismissal of Platinum Litigation Businesswire
30.10.18 Navidea Biopharmaceuticals Receives Acceptance Letter from NYSE American Businesswire
11.10.18 Navidea Biopharmaceuticals to Present Data on the Manocept Platform at 2018 ACR Annual Meeting Businesswire
08.10.18 Navidea Biopharmaceuticals to Present at the 2018 BIO Investor Forum Businesswire
17.09.18 Navidea Biopharmaceuticals Announces Acceptance into the National Institutes of Health Commercialization Accelerator Program Businesswire
17.09.18 Navidea Biopharmaceuticals Announces Closing of a $3 Million Private Placement Businesswire
11.04.14 Navidea Pharmaceuticals Inc. Analyst Report: Long Term Market Potential of Lymphoseek does not Justify Current Valuation by BrokerBank Securities, Inc. PR Newswire
13.08.13 Robbins Arroyo LLP Is Investigating the Directors and Officers of Navidea Biopharmaceuticals, Inc. PR Newswire
03.06.13 SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Navidea Biopharmaceuticals, Inc. PR Newswire
11.09.12 Navidea Biopharmaceuticals-​Aktie: "buy" - Ladenburg Thalmann Aktiencheck
11.09.12 Navidea Biopharmaceuticals-​Aktie: Kursziel gesenkt - Rodman & Renshaw Aktiencheck
22.08.12 Navidea Biopharmaceuticals-​Aktie: "buy" - ThinkEquity Partners Aktiencheck
31.07.12 Alseres Pharmaceuticals, Inc. Reports License of Altropane® Worldwide Rights to Navidea Biopharmaceuticals, Inc. PR Newswire
23.07.12 Navidea Biopharmaceuticals-​Aktie: vielversprechende Pipeline - Hot Stocks Investor Aktiencheck

Newssuche